drug · protein
patient view →sargramostim
Phase 3updated 2mo agoby Partner Therapeutics Inc🔗 ChEMBL
Phase 3community read0 votes
Protein drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 42 investigational indications.
targets
Granulocyte-macrophage colony-stimulating factor receptor
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that